A detailed history of Mario Gabelli (Gamco Investors, Inc. Et Al) transactions in Chroma Dex Corp. stock. As of the latest transaction made, Gamco Investors, Inc. Et Al holds 233,150 shares of CDXC stock, worth $855,660. This represents 0.01% of its overall portfolio holdings.

Number of Shares
233,150
Previous 263,850 11.64%
Holding current value
$855,660
Previous $918,000 30.72%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$2.44 - $4.32 $74,908 - $132,624
-30,700 Reduced 11.64%
233,150 $636,000
Q1 2024

May 14, 2024

BUY
$1.36 - $3.84 $5,440 - $15,360
4,000 Added 1.54%
263,850 $918,000
Q3 2023

Nov 08, 2023

BUY
$1.36 - $1.77 $74,120 - $96,465
54,500 Added 26.54%
259,850 $379,000
Q2 2023

Aug 10, 2023

BUY
$1.31 - $1.79 $37,728 - $51,552
28,800 Added 16.31%
205,350 $322,000
Q1 2023

May 12, 2023

BUY
$1.48 - $2.19 $261,294 - $386,644
176,550 New
176,550 $270,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $251M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track Mario Gabelli's Portfolio

Track Mario Gabelli Portfolio

Follow Mario Gabelli (Gamco Investors, Inc. Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.